OpenAI Codex v0.111.0 (research preview)
--------
workdir: /Users/mac/Documents/PROJECTS/qinnovates/qinnovate
model: gpt-5.2-codex
provider: openai
approval: never
sandbox: read-only
reasoning effort: medium
reasoning summaries: none
session id: 019cf004-ea55-7041-bcce-7599abb127ac
--------
user
Read the file docs/research/tier3-cross-ai-review.md. You are a scientific reviewer. Challenge every verdict in the table. Be adversarial. Flag anything too lenient. Output a markdown table: | # | Your Verdict | Agree? | Concern | Action |. Do NOT modify any files.
mcp startup: no servers

thinking
**Planning file read via command execution**
exec
/bin/zsh -lc "sed -n '1,220p' /Users/mac/Documents/PROJECTS/qinnovates/qinnovate/docs/research/tier3-cross-ai-review.md" in /Users/mac/Documents/PROJECTS/qinnovates/qinnovate succeeded in 52ms:
# Tier 3 Claims Cross-AI Review

## Context
QIF is a proposed BCI security framework (not peer-reviewed, not adopted). The whitepaper contains 17 claims flagged as Tier 3 (math, physics, engineering benchmarks, clinical mappings). An 8-agent Claude Quorum swarm reviewed all 17. Your job: challenge the swarm's verdicts. Flag anything the swarm got wrong, was too lenient on, or missed entirely.

## Quorum Verdicts to Challenge

| # | Claim | Quorum Verdict | Quorum Action |
|---|-------|---------------|---------------|
| 1 | Subvocalization BCI as "deployed" | PARTIALLY VERIFIED | QUALIFY to "emerging research" |
| 2 | M1 stimulation for gait correction | PARTIALLY VERIFIED | QUALIFY, cite studies |
| 3 | BCI-mediated withdrawal management | PARTIALLY VERIFIED | QUALIFY, distinguish peripheral vs cortical |
| 4 | Motor cortex override of fatigue/structural limits | UNVERIFIED | QUALIFY or REMOVE |
| 5 | Tissue damage at ~41C (attributed to Shannon 1992) | PARTIALLY VERIFIED | QUALIFY — Shannon is electrical, not thermal |
| 6 | VTA/NAc safe stimulation parameters | UNVERIFIED | QUALIFY as experimental |
| 7 | 10-20 year implant lifetime | PARTIALLY VERIFIED | QUALIFY by implant type |
| 8 | Neural biomarker auth stability | PARTIALLY VERIFIED | QUALIFY (short-term only) |
| 9 | 30-second coherence check interval | UNVERIFIED/AI-DERIVED | QUALIFY as design choice |
| 10 | 10% psychological continuity threshold | UNVERIFIED/AI-DERIVED | KEEP (already qualified in text) |
| 11 | 67.8% compression ratio (Forge v1.0) | VERIFIED from PoC | KEEP |

thinking
**Generating adversarial verdict table**

I'm preparing a markdown table listing each verdict with numbered entries and providing challenging concerns for each, without modifying any files.
codex
| # | Your Verdict | Agree? | Concern | Action |
|---|---|---|---|---|
| 1 | UNVERIFIED | No | “Deployed” is a strong commercialization/adoption claim. “Emerging research” still implies meaningful deployment; likely premature without clear, public operational systems. | REMOVE “deployed”; require concrete, independently verifiable deployments and regulatory status. |
| 2 | UNVERIFIED | No | M1 stimulation for gait correction is at best experimental/adjunct and highly condition-specific (e.g., stroke rehab). “Partially verified” risks overstating clinical efficacy. | QUALIFY as limited, small-cohort, experimental; require RCT/meta-analytic support or remove. |
| 3 | UNVERIFIED | No | “BCI-mediated withdrawal management” is a sweeping clinical claim; conflates peripheral neuromodulation vs cortical BCI. Evidence likely sparse or indirect. | REMOVE or reframe as speculative; require direct clinical trials for withdrawal outcomes. |
| 4 | UNVERIFIED | No | “QUALIFY or REMOVE” is too lenient. “Motor cortex override of fatigue/structural limits” implies biologically impossible or unsafe outcomes. | REMOVE entirely unless it is redefined as motivation/perception changes with strict limits. |
| 5 | UNVERIFIED | No | Shannon 1992 is about electrical safety, not thermal injury. Attributing 41C tissue damage threshold to Shannon is a mis-citation; thermal thresholds vary by tissue and exposure duration. | REMOVE the attribution; if temperature threshold retained, require correct thermal literature and context. |
| 6 | UNVERIFIED | No | VTA/NAc safe stimulation parameters are highly experimental; “QUALIFY as experimental” still implies meaningful safety knowledge. | REMOVE or replace with “unknown; requires preclinical safety profiling.” |
| 7 | UNVERIFIED | No | “10–20 year implant lifetime” is a strong reliability claim; depends on device class, encapsulation, failure modes, and clinical follow-up. “Partially verified” too generous. | QUALIFY by device type with hard data or REMOVE. |
| 8 | UNVERIFIED | No | “Neural biomarker auth stability” is nontrivial; short-term stability doesn’t translate to long-term biometric reliability or security. | QUALIFY as lab-only short-term; require longitudinal, adversarial testing. |
| 9 | UNVERIFIED | No | “30-second coherence check interval” is arbitrary; labeling as “design choice” still implies acceptability. Needs performance/security analysis. | REMOVE or clearly mark as speculative parameter requiring validation. |
| 10 | UNVERIFIED | No | “10% psychological continuity threshold” is an invented numeric threshold; even if text qualified, keeping it risks false precision. | REMOVE numeric threshold; replace with qualitative discussion or empirical basis. |
| 11 | UNVERIFIED | No | “Verified from PoC” is too lenient; PoC does not validate reproducibility, dataset representativeness, or compression tradeoffs. | QUALIFY as internal PoC only; require independent replication and datasets. |
| 12 | UNVERIFIED | No | “Verified from PoC” again too lenient; frame size depends on data format and pipeline assumptions. | QUALIFY as internal PoC; require external validation. |
| 13 | UNVERIFIED | No | “NISS v2.0 ICD-11 scope” being “verified” sounds like a definitional/coverage claim; likely internal mapping rather than external validation. | QUALIFY as proposed mapping; require public alignment checks and clinical coding review. |
| 14 | UNVERIFIED | No | “KEEP (labeled as proposed)” is too lenient; the weighting factors imply methodological rigor without evidence. | QUALIFY as unvalidated heuristic; require methodology or remove from claims. |
| 15 | UNVERIFIED | No | Severity scale for non-DSM outcomes being “AI-derived” should not be kept without validation. | REMOVE or reframe as draft proposal pending validation. |
| 16 | UNVERIFIED | No | Stale counts indicate weak data governance; recompute is necessary but also demands provenance, methodology, and versioning. | RECOMPUTE with full methodology and timestamp; treat prior counts as unreliable. |
| 17 | UNVERIFIED | No | “Verified (DOIs confirmed)” only checks citations exist, not that the cited works support the claim. This is too lenient. | CHECK actual claim alignment with those papers; downgrade until content is confirmed. |
tokens used
3,643
| # | Your Verdict | Agree? | Concern | Action |
|---|---|---|---|---|
| 1 | UNVERIFIED | No | “Deployed” is a strong commercialization/adoption claim. “Emerging research” still implies meaningful deployment; likely premature without clear, public operational systems. | REMOVE “deployed”; require concrete, independently verifiable deployments and regulatory status. |
| 2 | UNVERIFIED | No | M1 stimulation for gait correction is at best experimental/adjunct and highly condition-specific (e.g., stroke rehab). “Partially verified” risks overstating clinical efficacy. | QUALIFY as limited, small-cohort, experimental; require RCT/meta-analytic support or remove. |
| 3 | UNVERIFIED | No | “BCI-mediated withdrawal management” is a sweeping clinical claim; conflates peripheral neuromodulation vs cortical BCI. Evidence likely sparse or indirect. | REMOVE or reframe as speculative; require direct clinical trials for withdrawal outcomes. |
| 4 | UNVERIFIED | No | “QUALIFY or REMOVE” is too lenient. “Motor cortex override of fatigue/structural limits” implies biologically impossible or unsafe outcomes. | REMOVE entirely unless it is redefined as motivation/perception changes with strict limits. |
| 5 | UNVERIFIED | No | Shannon 1992 is about electrical safety, not thermal injury. Attributing 41C tissue damage threshold to Shannon is a mis-citation; thermal thresholds vary by tissue and exposure duration. | REMOVE the attribution; if temperature threshold retained, require correct thermal literature and context. |
| 6 | UNVERIFIED | No | VTA/NAc safe stimulation parameters are highly experimental; “QUALIFY as experimental” still implies meaningful safety knowledge. | REMOVE or replace with “unknown; requires preclinical safety profiling.” |
| 7 | UNVERIFIED | No | “10–20 year implant lifetime” is a strong reliability claim; depends on device class, encapsulation, failure modes, and clinical follow-up. “Partially verified” too generous. | QUALIFY by device type with hard data or REMOVE. |
| 8 | UNVERIFIED | No | “Neural biomarker auth stability” is nontrivial; short-term stability doesn’t translate to long-term biometric reliability or security. | QUALIFY as lab-only short-term; require longitudinal, adversarial testing. |
| 9 | UNVERIFIED | No | “30-second coherence check interval” is arbitrary; labeling as “design choice” still implies acceptability. Needs performance/security analysis. | REMOVE or clearly mark as speculative parameter requiring validation. |
| 10 | UNVERIFIED | No | “10% psychological continuity threshold” is an invented numeric threshold; even if text qualified, keeping it risks false precision. | REMOVE numeric threshold; replace with qualitative discussion or empirical basis. |
| 11 | UNVERIFIED | No | “Verified from PoC” is too lenient; PoC does not validate reproducibility, dataset representativeness, or compression tradeoffs. | QUALIFY as internal PoC only; require independent replication and datasets. |
| 12 | UNVERIFIED | No | “Verified from PoC” again too lenient; frame size depends on data format and pipeline assumptions. | QUALIFY as internal PoC; require external validation. |
| 13 | UNVERIFIED | No | “NISS v2.0 ICD-11 scope” being “verified” sounds like a definitional/coverage claim; likely internal mapping rather than external validation. | QUALIFY as proposed mapping; require public alignment checks and clinical coding review. |
| 14 | UNVERIFIED | No | “KEEP (labeled as proposed)” is too lenient; the weighting factors imply methodological rigor without evidence. | QUALIFY as unvalidated heuristic; require methodology or remove from claims. |
| 15 | UNVERIFIED | No | Severity scale for non-DSM outcomes being “AI-derived” should not be kept without validation. | REMOVE or reframe as draft proposal pending validation. |
| 16 | UNVERIFIED | No | Stale counts indicate weak data governance; recompute is necessary but also demands provenance, methodology, and versioning. | RECOMPUTE with full methodology and timestamp; treat prior counts as unreliable. |
| 17 | UNVERIFIED | No | “Verified (DOIs confirmed)” only checks citations exist, not that the cited works support the claim. This is too lenient. | CHECK actual claim alignment with those papers; downgrade until content is confirmed. |
